Sanofi (NASDAQ: SNY) was downgraded by analysts at Kepler Capital Markets from a "buy" rating to a "hold" rating. They now have a €89.00 price target on the stock, down previously fr...
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDAGlobeNewswire
- Rolls-Royce CEO fired managers and held staff brainstorms as part of a ‘4 pillar' turnaround plan that led to 500% share price jump [Fortune]Fortune
- Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosisGlobeNewswire
- Clearlake Gets $5.75 Billion Loan for Dun & Bradstreet Deal [Yahoo! Finance Canada]Yahoo! Finance Canada
- Press Release: Availability of the Q1 2025 Aide mémoireGlobeNewswire
SNY
Sec Filings
- 3/26/25 - Form 6-K
- 3/21/25 - Form S-8
- 3/20/25 - Form 6-K
- SNY's page on the SEC website